输尿管软镜吸引技术证据图:FANS与DISS的研究特征与趋势
该证据图系统检索了PubMed、EMBASE和Web of Science,纳入154项研究(2022-2026年),描述FANS和DISS在输尿管软镜中的研究设计、地域与时间趋势、偏倚风险及临床应用。年发文量从2022年3项增至2025年>80项,中国占48.7%;成人泌尿系结石占临床研究72%,RCT证据仅见于FANS,DISS证据尚不成熟。
要点
- FANS与DISS文献快速增长,以亚洲单中心回顾性研究为主。
- 成人结石占临床研究72%,儿童研究仅2.6%且限于FANS。
- RCT证据仅FANS初现,DISS证据阶段较早、成熟度低。
核心结论
- FANS和DISS文献快速扩展,但以亚洲单中心回顾性研究为主,RCT证据仅FANS初现。
研究设计与样本
- 系统证据图,检索PubMed、EMBASE和Web of Science,纳入154项研究(2022-2026年),所有研究设计均合格。
- 采用RoB 2、ROBINS-I、QUIN和Newcastle-Ottawa量表评估偏倚风险。
- 国家按第一作者单位归属分配,作为研究领导力的替代指标。
主要发现
- 年发文量从2022年3项增至2025年>80项;中国占48.7%,新加坡11.7%,亚美尼亚5.2%。
- 回顾性比较研究最多(49项,31.8%),其次为体外实验(22项,14.3%)、前瞻性比较研究(19项,12.3%)和RCT(11项,7.1%)。
- 临床研究单中心占55.8%;多中心合作在前瞻性研究和EAU附属研究中更常见。
- 成人泌尿系结石占临床研究72%,儿童研究占2.6%(仅FANS)。
- ROBINS-I评估61%观察性研究为中等偏倚风险;RoB 2评估81% RCT存在一些担忧;实验室研究多为低偏倚风险。
临床怎么用
- 当前证据以单中心回顾性研究为主,临床决策需谨慎解读FANS和DISS的疗效。
- FANS已有RCT证据初现,DISS证据尚早,选择技术时应关注证据成熟度差异。
- 未来需标准化结局报告、多中心前瞻性设计和更广泛地域代表性。
局限性
- 国家按第一作者单位归属分配,可能不能完全反映研究领导力。
- 多数临床研究为单中心回顾性设计,偏倚风险中等。
- 儿童研究仅2.6%且限于FANS,外推受限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To characterise the global research landscape of suction technologies in flexible ureteroscopy, specifically the flexible and navigable suction ureteric access sheath (FANS) and direct-in-scope suction (DISS), mapping study design, geographical and temporal trends, risk of bias, and clinical and experimental applications. METHODS: A systematic search of PubMed, the Excerpta Medica dataBASE (EMBASE), and Web of Science was performed per Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines (International Prospective Register of Systematic Reviews: CRD420261371338). All study designs were eligible, including randomised controlled trials (RCTs), prospective and retrospective observational studies, experimental studies (in vivo, ex vivo, in vitro), and case series. Country was assigned by first-author affiliation as a proxy for research leadership. Risk of bias was assessed with design-appropriate tools: the Cochrane Risk of Bias 2 (RoB 2) tool for RCTs, Risk Of Bias In Non-randomised Studies of Interventions (ROBINS-I) for non-randomised studies, Quality Assessment Tool For In Vitro Studies (QUIN) for laboratory studies, and the Newcastle-Ottawa Scale for case series. RESULTS: A total of 154 studies were included (2022-2026). Annual publication rate increased from three studies in 2022 to >80 in 2025. China accounted for 48.7% of publications, followed by Singapore (11.7%) and Armenia (5.2%). Retrospective comparative studies were the largest design group (49 [31.8%]), followed by in vitro experiments (22 [14.3%]), prospective comparative studies (19 [12.3%]), and RCTs (11 [7.1%]). Most clinical studies were single-centre (55.8%); multicentre collaboration was more common in prospective and European Association of Urology-affiliated research. Adult urolithiasis accounted for 72% of clinical studies; paediatric studies, 2.6% (FANS only). Under ROBINS-I, 61% of observational studies were rated moderate risk of bias; 81% of RCTs raised some concerns under RoB 2; laboratory studies were predominantly low risk. CONCLUSIONS: This evidence map shows FANS and DISS have generated a rapidly expanding literature, heavily dominated by single-centre retrospective studies from Asia. RCT-level evidence is emerging for FANS, while DISS evidence remains earlier-stage and less mature. Standardised outcome reporting, multicentre prospective designs, and broader geographic representation are the priorities this evidence map identifies for the field.
引用
- Scilipoti P, Zorzi F, Gonzalez CG, et al. Flexible and navigable suction ureteric access sheath and direct-in-scope suction in endourology: a systematic evidence map of study characteristics and research trends. BJU Int. 2026. PMID: 42888853. doi:10.1111/bju.70498
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。